| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
391,541,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
14,763,294 |
Avg
Vol: |
6,903,207 |
| 52
Week Range: |
$70.3 - $70.3 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Retail |
| Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smith Jack Allen |
SVP, Chief Marketing Officer |
• – – |
2006-08-11 |
4 |
S |
$63.00 |
$1,463,092 |
D/D |
(23,184) |
28,871 |
|
- |
|
| Smith Jack Allen |
SVP, Chief Marketing Officer |
• – – |
2006-08-11 |
4 |
OE |
$26.92 |
$807,600 |
D/D |
30,000 |
52,055 |
|
- |
|
| Klepper Kenneth O |
President-Chief Oper. Officer |
• – – |
2006-08-10 |
4 |
AS |
$64.00 |
$928,000 |
D/D |
(14,500) |
93,055 |
|
- |
|
| Klepper Kenneth O |
President-Chief Oper. Officer |
• – – |
2006-08-10 |
4 |
OE |
$32.51 |
$577,930 |
D/D |
17,777 |
107,555 |
|
- |
|
| Klepper Kenneth O |
President-Chief Oper. Officer |
• – – |
2006-08-08 |
4 |
AS |
$62.00 |
$899,000 |
D/D |
(14,500) |
89,778 |
|
- |
|
| Klepper Kenneth O |
President-Chief Oper. Officer |
• – – |
2006-08-08 |
4 |
OE |
$32.51 |
$577,963 |
D/D |
17,778 |
104,278 |
|
- |
|
| Klepper Kenneth O |
President-Chief Oper. Officer |
• – – |
2006-07-24 |
4 |
AS |
$60.00 |
$870,000 |
D/D |
(14,500) |
86,500 |
|
- |
|
| Klepper Kenneth O |
President-Chief Oper. Officer |
• – – |
2006-07-24 |
4 |
OE |
$32.51 |
$577,963 |
D/D |
17,778 |
101,000 |
|
- |
|
| Nardin Arthur H |
SVP, Pharma Contracting |
• – – |
2006-07-12 |
4 |
AS |
$58.95 |
$2,172,131 |
D/D |
(36,847) |
46,478 |
|
- |
|
| Wilson Blenda J |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,000 |
|
- |
|
| Strom Brian L |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,000 |
|
- |
|
| Shortliffe Edward H |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,000 |
|
- |
|
| Lillis Charles M |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
10,500 |
|
- |
|
| Lewin Lawrence S |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,578 |
|
- |
|
| Goldstein Michael |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,000 |
|
- |
|
| Cassis John L |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
15,000 |
|
- |
|
| Barker Howard W Jr |
Director |
– • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
13,012 |
|
- |
|
| Goldstein Michael |
Director |
– • – |
2006-05-09 |
4 |
B |
$51.10 |
$51,100 |
I/I |
1,000 |
4,000 |
2.1 |
- |
|
| Stevens David D |
Director |
– • – |
2006-03-29 |
4 |
B |
$58.97 |
$2,949 |
D/D |
50 |
69,770 |
2.31 |
- |
|
| Stevens David D |
Director |
– • – |
2006-03-27 |
4 |
B |
$58.59 |
$5,859 |
D/D |
100 |
69,720 |
2.39 |
- |
|
| Nardin Arthur H |
SVP, Pharma Contracting |
• – – |
2006-03-24 |
4 |
AS |
$60.00 |
$2,587,628 |
D/D |
(43,122) |
83,325 |
|
- |
|
| Nardin Arthur H |
SVP, Pharma Contracting |
• – – |
2006-03-24 |
4 |
OE |
$26.92 |
$1,457,800 |
D/D |
50,000 |
126,447 |
|
- |
|
| Epstein Robert S |
SVP Medical Affairs & CMO |
• – – |
2006-03-15 |
4 |
AS |
$58.85 |
$603,519 |
D/D |
(10,250) |
57,889 |
|
- |
|
| Wentworth Timothy C |
President & CEO - Accredo |
• – – |
2006-03-10 |
4 |
AS |
$58.90 |
$3,698,308 |
D/D |
(62,728) |
54,792 |
|
- |
|
| Wentworth Timothy C |
President & CEO - Accredo |
• – – |
2006-03-10 |
4 |
OE |
$26.92 |
$1,371,096 |
D/D |
47,333 |
117,520 |
|
- |
|
672 Records found
|
|
Page 20 of 27 |
|
|
